198 related articles for article (PubMed ID: 29932108)
1. Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology.
Aguirre-Plans J; Piñero J; Menche J; Sanz F; Furlong LI; Schmidt HHHW; Oliva B; Guney E
Pharmaceuticals (Basel); 2018 Jun; 11(3):. PubMed ID: 29932108
[TBL] [Abstract][Full Text] [Related]
2. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
[TBL] [Abstract][Full Text] [Related]
3. Topology Driven Analysis of Protein - Protein Interactome for Prioritizing Key Comorbid Genes via Sub Graph Based Average Path Length Centrality.
Suresh NT; E R V; Krishnakumar U
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(1):742-751. PubMed ID: 34986099
[TBL] [Abstract][Full Text] [Related]
4. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W; Bai Y; Wang Y; Xiao W
Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine.
Shen Z; Pu S; Cao X; Tang M; Wang S; Bai D; Jiang G
Epilepsy Res; 2023 Jan; 189():107066. PubMed ID: 36571905
[TBL] [Abstract][Full Text] [Related]
7. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
8. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
9. Predicting COVID-19-Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management.
Barh D; Aljabali AA; Tambuwala MM; Tiwari S; Serrano-Aroca Á; Alzahrani KJ; Silva Andrade B; Azevedo V; Ganguly NK; Lundstrom K
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067609
[TBL] [Abstract][Full Text] [Related]
10. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
[TBL] [Abstract][Full Text] [Related]
11. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
12. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.
Truong TTT; Panizzutti B; Kim JH; Walder K
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890359
[TBL] [Abstract][Full Text] [Related]
14. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder.
Guo P; Chen S; Wang H; Wang Y; Wang J
Front Aging Neurosci; 2021; 13():789698. PubMed ID: 35126089
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19.
Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL
Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255
[TBL] [Abstract][Full Text] [Related]
17. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
Barneh F; Jafari M; Mirzaie M
Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
[TBL] [Abstract][Full Text] [Related]
18. Symptom-based network classification identifies distinct clinical subgroups of liver diseases with common molecular pathways.
Shu Z; Liu W; Wu H; Xiao M; Wu D; Cao T; Ren M; Tao J; Zhang C; He T; Li X; Zhang R; Zhou X
Comput Methods Programs Biomed; 2019 Jun; 174():41-50. PubMed ID: 29502851
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insight of the potential of geraniol against Alzheimer's disease.
Liu Y; Zhou S; Huang X; Rehman HM
Eur J Med Res; 2022 Jun; 27(1):93. PubMed ID: 35701806
[TBL] [Abstract][Full Text] [Related]
20. Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
Oliveros G; Wallace CH; Chaudry O; Liu Q; Qiu Y; Xie L; Rockwell P; Figueiredo-Pereira ME; Serrano PA
Brain; 2023 Mar; 146(3):898-911. PubMed ID: 35411386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
